Disrupted Calcium Signaling in Animal Models of Human Spinocerebellar Ataxia (SCA)
Overview
Chemistry
Molecular Biology
Affiliations
Spinocerebellar ataxias (SCAs) constitute a heterogeneous group of more than 40 autosomal-dominant genetic and neurodegenerative diseases characterized by loss of balance and motor coordination due to dysfunction of the cerebellum and its efferent connections. Despite a well-described clinical and pathological phenotype, the molecular and cellular events that underlie neurodegeneration are still poorly undaerstood. Emerging research suggests that mutations in SCA genes cause disruptions in multiple cellular pathways but the characteristic SCA pathogenesis does not begin until calcium signaling pathways are disrupted in cerebellar Purkinje cells. Ca signaling in Purkinje cells is important for normal cellular function as these neurons express a variety of Ca channels, Ca2+-dependent kinases and phosphatases, and Ca-binding proteins to tightly maintain Ca homeostasis and regulate physiological Ca-dependent processes. Abnormal Ca levels can activate toxic cascades leading to characteristic death of Purkinje cells, cerebellar atrophy, and ataxia that occur in many SCAs. The output of the cerebellar cortex is conveyed to the deep cerebellar nuclei (DCN) by Purkinje cells via inhibitory signals; thus, Purkinje cell dysfunction or degeneration would partially or completely impair the cerebellar output in SCAs. In the absence of the inhibitory signal emanating from Purkinje cells, DCN will become more excitable, thereby affecting the motor areas receiving DCN input and resulting in uncoordinated movements. An outstanding advantage in studying the pathogenesis of SCAs is represented by the availability of a large number of animal models which mimic the phenotype observed in humans. By mainly focusing on mouse models displaying mutations or deletions in genes which encode for Ca signaling-related proteins, in this review we will discuss the several pathogenic mechanisms related to deranged Ca homeostasis that leads to significant Purkinje cell degeneration and dysfunction.
Yang C, Liu G, Chen X, Le W MedComm (2020). 2024; 5(7):e638.
PMID: 39006764 PMC: 11245631. DOI: 10.1002/mco2.638.
LItalien G, Oikonomou E, Khera R, Potashman M, Beiner M, Maclaine G Neurol Ther. 2024; 13(4):1287-1301.
PMID: 38814532 PMC: 11263303. DOI: 10.1007/s40120-024-00625-6.
Sekerkova G, Kilic S, Cheng Y, Fredrick N, Osmani A, Kim H Neurobiol Dis. 2024; 195:106492.
PMID: 38575093 PMC: 11089908. DOI: 10.1016/j.nbd.2024.106492.
Martuscello R, Chen M, Reiken S, Sittenfeld L, Ruff D, Ni C Acta Neuropathol. 2023; 146(2):301-318.
PMID: 37335342 PMC: 10350926. DOI: 10.1007/s00401-023-02602-z.
Del Bondio A, Longo F, De Ritis D, Spirito E, Podini P, Brais B JCI Insight. 2023; 8(12).
PMID: 37159335 PMC: 10371240. DOI: 10.1172/jci.insight.163576.